Related Experiment Video
Updated: Nov 21, 2025

Anesthesia and Intubation of Preadolescent Mouse Pups for Cardiothoracic Surgery
Published on: June 2, 2022
Methadone: applications in pediatric anesthesiology and critical care medicine
1Department of Anesthesiology and Pain Medicine, Nationwide Children's Hospital and The Ohio State University, 700 Children's Drive, Columbus, OH , 43205, USA. Joseph.Tobias@Nationwidechildrens.org.
Abstract:
Like morphine, methadone is a pure agonist at the µ opioid receptor. However, in distinction to morphine which has an elimination half-life of 2-3 h, methadone has an elimination half-life of 24-36 h. In addition to its effects at the µ opioid receptor, methadone is an antagonist at the N-methyl-D-aspartate (NMDA) receptor and also inhibits the reuptake of the neurotransmitters, serotonin and norepinephrine, in the central nervous system. Given its long half-life and high oral bioavailability, methadone has had a primary role in the outpatient treatment of patients with a history of opioid abuse or addiction. However, its unique pharmacology and cellular effects make it a valuable agent in the treatment of both acute and chronic pain of various etiologies. The following manuscript reviews the pharmacologic properties of methadone and discusses its clinical applications in the practice of pediatric anesthesiology and pediatric critical care medicine.
Insights
Methadone, a long-acting µ-opioid receptor agonist, offers versatile pain management. Its unique pharmacology also targets NMDA receptors and neurotransmitter reuptake, benefiting pediatric anesthesiology and critical care.
Area of Science:
- Pharmacology
- Neuroscience
- Pain Management
Background:
- Methadone is a pure µ-opioid receptor agonist, similar to morphine but with a significantly longer elimination half-life (24-36 hours vs. 2-3 hours).
- Beyond µ-opioid agonism, methadone exhibits unique pharmacological actions including N-methyl-D-aspartate (NMDA) receptor antagonism and inhibition of serotonin and norepinephrine reuptake in the central nervous system.
Purpose of the Study:
- To review the pharmacologic properties of methadone.
- To discuss the clinical applications of methadone in pediatric anesthesiology and pediatric critical care medicine.
Main Methods:
- Literature review of methadone's pharmacologic properties.
- Analysis of clinical applications in pediatric pain management and critical care.
Main Results:
- Methadone's long half-life and high oral bioavailability facilitate outpatient treatment for opioid abuse.
- Its multifaceted pharmacology makes it effective for managing diverse acute and chronic pain conditions.
Conclusions:
- Methadone's unique pharmacologic profile supports its use beyond opioid addiction treatment.
- The manuscript highlights methadone's value in pediatric anesthesiology and critical care settings.
More Related Videos
12:40A Modified Murine Heterotopic Heart Transplant Protocol Matching Contemporary Standards of Aseptic Technique, Anesthesia, and Analgesia
Published on: September 28, 2022
06:59A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
Related Concept Videos
Parenteral Anesthetics: Overview
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Analgesia and Pain Management
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...